Cornea Project

corneaproject.com ↗ ·Barcelona ·Seed

Cornea Project is a Barcelona-based ophthalmology healthtech company that develops technology for the early diagnosis and treatment of eye diseases. It is building a non-invasive point-of-care device that uses a disposable card to measure corneal biomarkers and aims to give a result during the same consultation, in under 30 minutes. Its first target is subclinical keratoconus, and it plans to extend the platform to glaucoma, age-related macular degeneration and diabetic retinopathy. The company was founded in 2015 by Pere del Campo and Sigfrid Borràs and works with Centro de Oftalmología Barraquer and Massachusetts Eye and Ear, with US commercialisation handled by its subsidiary PreVista Diagnostics Inc. It has raised about €2 million over several rounds, including a 2020 round of about €1 million, most of it (€874,500) from 365 investors on Capital Cell, led by AJL Ophthalmic, with Namarel Ventures and Catalonia.Health also among its backers.

Founded
2015
Founders
2
Total funds raised
€1.3M
Rounds
2
Investors
4
Last round
Dec 2020
SectorsHealthtech, Medical Devices, Diagnostics, Ophthalmology Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing

Suggest a correction

Founders

Pere del Campo
Co-founder & CEO
Sigfrid Borràs
Co-founder

Global models 4

Avellino Labs
United States · avellino.com ↗
Sells diagnostic tests that detect keratoconus and other corneal disease risk early to eye clinics, the same first target as Cornea Project.
$60MComparable
TearLab
United States · www.tearlab.com ↗
Makes a point-of-care device with disposable test cards that measures a tear-film biomarker in the eye doctor's office in minutes.
$30MComparable
Rapid Pathogen Screening
United States
Developed InflammaDry, a disposable point-of-care test that detects an ocular inflammation biomarker during the consultation; acquired by Quidel.
$30MComparable
Advanced Tear Diagnostics
Sells the TearScan point-of-care platform that measures tear biomarkers such as lactoferrin and IgE in-office to diagnose eye disease.
$10MComparable

In the same niche 48 others

See all in the Start-ups Map →

Notes: Most funded first

Investors 4

Open as list →
Capital Cell
capitalcell.com
Seed 2020 Spain
Namarel Ventures
namarelventures.com
Investor Spain
AJL Ophthalmic
2 rounds, led 1 · 2017–20 Spain
Catalonia.Health
Investor Spain

Funding rounds 2

DateRoundAmountLead

News

No coverage on record yet.
Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list